Taylor Pedersen
Family Medicine · Casper, WYNPI 1043740202
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,449 of the $3,934 with a category attached, or 87.7%. It is spread thinly across 29 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in WY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 232 payments — averaging $16.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$583
- Henry Schein, Inc.$485
- Lilly USA, LLC$371
- Pfizer$352
- AbbVie$305
- Merck$260
- plus $2K from 23 others
What the payments were for
- Travel & lodging$48512%
- Food & beverage$3,44988%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 34 | $583 |
| Henry Schein, Inc. | 2 | $485 |
| Lilly USA, LLC | 23 | $371 |
| Pfizer | 33 | $352 |
| AbbVie(2 entities) | 26 | $305 |
| Merck | 16 | $260 |
| Novo Nordisk | 13 | $241 |
| GSK | 11 | $147 |
| Amgen | 10 | $133 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $132 |
| Boehringer Ingelheim | 8 | $112 |
| Otsuka America Pharmaceutical, Inc. | 7 | $109 |
| Organon | 8 | $100 |
| Globus Medical | 2 | $94 |
| Astellas Pharma US Inc | 4 | $81 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $77 |
| Vanda Pharmaceuticals Inc. | 2 | $46 |
| Teva Pharmaceuticals USA, Inc. | 3 | $43 |
| Bayer | 3 | $41 |
| Lundbeck LLC | 2 | $35 |
| Exact Sciences | 2 | $29 |
| Sanofi-aventis U.S. LLC | 2 | $29 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $25 |
| Idorsia Pharmaceuticals US Inc | 1 | $21 |
| Avanir Pharmaceuticals, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$3,934 in reported general payments places this provider in the 90th percentile of 237 family medicine providers in Wyoming.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 95 | $102,047 |
| TrulicityDulaglutide | 56 | $54,174 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 60 | $48,879 |
| JardianceEmpagliflozin | 45 | $41,670 |
| EliquisApixaban | 37 | $38,740 |
| FarxigaDapagliflozin Propanediol | 21 | $20,977 |
| MounjaroTirzepatide | 19 | $19,751 |
| MyrbetriqMirabegron | 39 | $19,088 |
| XareltoRivaroxaban | 27 | $18,592 |
| Spiriva RespimatTiotropium Bromide | 31 | $17,394 |
| Nurtec OdtRimegepant Sulfate | 12 | $16,587 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 18 | $11,717 |
| JanuviaSitagliptin Phosphate | 14 | $11,571 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 14 | $8,518 |
| Breo ElliptaFluticasone/Vilanterol | 14 | $6,884 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $241 | $102,04795 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $371 | $73,92575 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat, Combivent Respimat | $112 | $67,58290 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta | $147 | $60,28987 claims |
| PfizerEliquis, Nurtec Odt | $352 | $55,32649 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $583 | $38,13963 claims |
| Astellas Pharma US IncMyrbetriq | $81 | $19,08839 claims |
| Johnson & JohnsonXarelto | $14 | $18,59227 claims |
| MerckJanuvia, Belsomra | $260 | $17,58128 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 237 family medicine providers in Wyoming.
Other family medicine in Casper
- Joseph SchoeberCasper$176K
- James McLennanCasper$13K
- Karlynn SieversCasper$10K
- Eric LawrenceCasper$7K
- Louis RoussalisCasper$5K
- Joseph MickelsonCasper$5K
- Jonathan BinderCasper$4K
- Sherrill FoxCasper$4K
- Tiffany SpauldingCasper$2K
- Brehan NewellCasper$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.